Comparison of intra-arterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 76, Issue 2, 2005, Pages 196-199

  Arnold, M ^a   Koerner, U ^a   Remonda, L ^a   Nedeltchev, K ^a   Mattle, H P ^a   Schroth, G ^a   Sturzenegger, M ^a   Weber, J ^a   Koerner, F ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOLYTIC AGENT; HEPARIN; UROKINASE;

ADULT; AGED; ARTICLE; BLEEDING; BLINDNESS; CASE CONTROL STUDY; CENTRAL RETINA ARTERY OCCLUSION; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PARACENTESIS; PREDICTION; PRIORITY JOURNAL; RETINA ANGIOGRAPHY; RETROSPECTIVE STUDY; STROKE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; VISUAL ACUITY;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BLINDNESS; CASE-CONTROL STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; RETINAL ARTERY OCCLUSION; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 12444343142     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2004.037135     Document Type: Article

References (14)

1. Augsburger JJ, Magargal LE. Visual prognosis following treatment of acute central retinal artery obstruction. Br J Ophthalmol 1980;64:913-17.
2. Atebara NH, Brown GC, Cater J. Efficacy of anterior chamber paracentesis and Carbogen in treating acute nonarteritic central retinal artery occlusion. Ophthalmology 1995;102:2029-34.
3. Schmidt D, Schumacher M, Wakhloo AK. Microcatheter urokinase infusion in central retinal artery occlusion. Am J Ophthalmol 1992;113:429-34.
4. Richard G, Lerche RC, Knospe V, et al. Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator. Ophthalmology 1999;106:768-73.
5. Schmidt DP, Schulte-Monting J, Schumacher M. Prognosis of central retinal artery occlusion: local intraarterial fibrinolysis versus conservative treatment. AJNR Am J Neuroradiol 2002;23:1301-7.
6. Beatty S, Au Eong KG. Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery: a meta-analysis of the published data. Br J Ophthalmol 2000;84:914-16.
7. Weber J, Remonda L, Mattle HP, et al. Selective intra-arterial fibrinolysis of acute central retinal artery occlusion. Stroke 1998;29:2076-9.
8. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
9. The International Stroke Trial (IST). A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997;34:1569-81.
10. Arnold M, Schroth G, Nedeltchev K, et al. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke 2002;33:1828-33.
11. Ueda T, Sakaki S, Kumon Y, et al. Multivariable analysis of predictive factors related to outcome at 6 months after intra-arterial thrombolysis for acute ischemic stroke. Stroke 1999;30:2360-5.
12. Hayreh SS, Kolder HE, Weingeist TA. Central retinal artery occlusion and retinal tolerance time. Ophthalmology 1980;87:75-8.
13. Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA Stroke Study. Neurology 2000;55:1649-55.
14. Kaste M. Approval of alteplase in Europe: will it change stroke management? Lancet Neurol 2003;2:207-8.